Effect of open prostatectomy versus transurethral prostatectomy on clinical and laboratory findings in patients with benign prostatic hyperplasia

Effect of open prostatectomy versus transurethral prostatectomy on clinical and laboratory findings in patients with benign prostatic hyperplasia: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201512219014N87

Enrollment

Registered

2016-01-03

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia. Hyperplasia of prostate

Interventions

Intervention 1: Prostate resection through transurethral prostatectomy. Intervention 2: Prostate resection through open surgery prostatectomy.

Treatment - Surgery

Prostate resection through transurethral prostatectomy

Prostate resection through open surgery prostatectomy

Eligibility

Sex/Gender

Male

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) having benign prostatic hyperplasia; (b) indication of prostatectomy. Exclusion criteria: (a) prostate greater than 100 gr or lower than 40 gr; (b) history of previous prostatic or urethral surgery; (c) having bladder stone.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing the urine flow. Timepoint: before and one month after intervention. Method of measurement: using uroflowmetry.;Assessing incontinency. Timepoint: before and one month after intervention. Method of measurement: by taking history.;Assessing number of nocturia. Timepoint: before and one month after intervention. Method of measurement: by taking history.;Assessing impotency. Timepoint: before and one month after intervention. Method of measurement: by taking history.	—

Measure

Time frame

Assessing the urine flow. Timepoint: before and one month after intervention. Method of measurement: using uroflowmetry.;Assessing incontinency. Timepoint: before and one month after intervention. Method of measurement: by taking history.;Assessing number of nocturia. Timepoint: before and one month after intervention. Method of measurement: by taking history.;Assessing impotency. Timepoint: before and one month after intervention. Method of measurement: by taking history.

—

Secondary

Measure	Time frame
Assessing prostatic specific antigen. Timepoint: before and one month after intervention. Method of measurement: through laboratory test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ehsan Ghaneei

Shahid Beheshti Hospital

e_ghaneei@yahoo.com+98 81 3838 0283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026